Product Information
DAPSONE 5% GEL is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.6750 per GM under NDC 65162033991. Its NADAC has been published 136 times since Feb 28, 2024.
FDA first approved this application on Oct 19, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162033991
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DAPSONEApproval Type
Generic (ANDA)
FDA Application
ANDA209890FDA Approved
10/19/2023
TE Code
AB
On Market Since
10/24/2023
Pharmacological Classes
Price Statistics
The NADAC for DAPSONE 5% GEL has been published 136 times since Feb 28, 2024, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6750 per GM |
|---|---|
| All-time high | $2.1429 (Mar 13, 2024) |
| All-time low | $0.6597 (Jul 22, 2026) |
| 52-week high | $1.2376 |
| 52-week low | $0.6597 |
| Median price | $1.2262 |
| Average price | $1.2910 |
| Largest weekly change | +23.5% (Oct 23, 2024) |
| Weeks tracked | 136 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dapsone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAPSONE 5% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DAPSONE 5% GEL, manufactured by Amneal Pharmaceuticals LLC, is $0.6750 per GM (NDC 65162033991), effective Sep 30, 2026.
How has the price of DAPSONE 5% GEL changed over time?
Over the history we have for it, the NADAC for DAPSONE 5% GEL has declined 68.5%. It has been tracked across 136 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for DAPSONE 5% GEL?
Since Feb 28, 2024, the NADAC for DAPSONE 5% GEL has ranged from a low of $0.6597 (Jul 22, 2026) to a high of $2.1429 (Mar 13, 2024), with a median of $1.2262 per GM.
Are there cheaper alternatives to DAPSONE 5% GEL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPSONE 5% GEL, is $0.6638 per GM — about 2% below DAPSONE 5% GEL.
Who manufactures DAPSONE 5% GEL?
DAPSONE 5% GEL (NDC 65162033991) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.